Dyne Therapeutics, Inc. Profile Avatar - Palmy Investing

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenn…

Biotechnology
US, Waltham [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

Dyne Therapeutics, Inc. has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of DYN's Analysis
CIK: 1818794 CUSIP: 26818M108 ISIN: US26818M1080 LEI: - UEI: -
Secondary Listings
DYN has no secondary listings inside our databases.